Repository logo
 

ESCRT-III-associated proteins and spastin inhibit protrudin-dependent polarised membrane traffic

Published version
Peer-reviewed

Change log

Authors

Connell, James W. 
Allison, Rachel J. 
Rodger, Catherine E. 
Pearson, Guy 
Zlamalova, Eliska 

Abstract

Abstract: Mutations in the gene encoding the microtubule severing ATPase spastin are the most frequent cause of hereditary spastic paraplegia, a genetic condition characterised by length-dependent axonal degeneration. Here, we show that HeLa cells lacking spastin and embryonic fibroblasts from a spastin knock-in mouse model become highly polarised and develop cellular protrusions. In HeLa cells, this phenotype was rescued by wild-type spastin, but not by forms unable to sever microtubules or interact with endosomal ESCRT-III proteins. Cells lacking the spastin-interacting ESCRT-III-associated proteins IST1 or CHMP1B also developed protrusions. The protrusion phenotype required protrudin, a RAB-interacting protein that interacts with spastin and localises to ER–endosome contact sites, where it promotes KIF5-dependent endosomal motility to protrusions. Consistent with this, the protrusion phenotype in cells lacking spastin also required KIF5. Lack or mutation of spastin resulted in functional consequences for receptor traffic of a pathway implicated in HSP, as Bone Morphogenetic Protein receptor distribution became polarised. Our results, therefore, identify a novel role for ESCRT-III proteins and spastin in regulating polarised membrane traffic.

Description

Funder: National Institute for Health Research; doi: http://dx.doi.org/10.13039/501100000272


Funder: Gates Cambridge Trust; doi: http://dx.doi.org/10.13039/501100005370

Keywords

Original Article, Protrusion formation, AAA ATPase, Axonopathy, Bone morphogenetic protein signalling, Microtubule modification

Journal Title

Cellular and Molecular Life Sciences

Conference Name

Journal ISSN

1420-682X
1420-9071

Volume Title

77

Publisher

Springer International Publishing
Sponsorship
Medical Research Council (MR/R026440/1, MR/M00046X/1, MR/K50127X/1)
Wellcome Trust (082381, 100140, 093026)